NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

NEXGEL (NASDAQ:NXGL) moved its shareholder update conference call to April 21, 2026 at 4:30 P.M.

Rhea-AI Summary

NEXGEL (NASDAQ:NXGL) moved its shareholder update conference call to April 21, 2026 at 4:30 P.M. ET to discuss the Celularity transaction. Investors can join via U.S. toll-free 1-800-267-6316, international 1-203-518-9783, or the company webcast under Events and Presentations.

Argus Apr 17 session

-1.47% close to close Open Argus

Details

News Market Reaction – NXGL

On Apr 17, the day this news came out, NXGL closed 1.47% below the previous close.

Data tracked by StockTitan Argus for the Apr 17 session.

Key Figures

Shareholder call date: April 21, 2026 Call time: 4:30 P.M. ET U.S. dial-in: 1-800-267-6316 +1 more

Shareholder call date

April 21, 2026

Rescheduled shareholder update call on Celularity transaction

Call time

4:30 P.M. ET

Start time of the April 21, 2026 shareholder update call

U.S. dial-in

1-800-267-6316

U.S. toll-free number for the shareholder update call

International dial-in

1-203-518-9783

International number for the shareholder update call

Historical Context

5 past events · Latest: Apr 15

5 events

1. Apr 15

   Call rescheduled update

   24h Move

   -15.3%

   Rescheduled shareholder call and financing change for Celularity transaction.

2. Apr 08

   Call rescheduled update

   24h Move

   -2.7%

   Rescheduled update; noted no assurance Celularity deal will close.

3. Mar 31

   Earnings call shift

   24h Move

   -1.3%

   Moved 2025 results call to focus more on Celularity transaction details.

4. Mar 25

   Earnings date set

   24h Move

   -1.0%

   Announced schedule for Q4 and full-year 2025 results call.

5. Mar 12

   Acquisition terms

   24h Move

   +16.2%

   Announced economic terms to license and acquire Celularity biomaterial portfolio.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

over-the-counter (otc), hydrogel

2 terms

over-the-counter (otc) medical

"products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications"

Over-the-counter (OTC) describes stocks and other securities traded directly between buyers and sellers outside formal exchanges, using brokers, dealers, or electronic networks. For investors it matters because OTC trading often means lower transparency, fewer rules and thinner trading volume—like buying at a small flea market instead of a big supermarket—so prices can swing more and the risk of not being able to sell quickly is higher.

hydrogel medical

"including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications"

A hydrogel is a soft, jelly-like material made mostly of water combined with a network of flexible, supportive molecules. Its unique ability to hold large amounts of water while remaining stable makes it useful in various medical, industrial, and consumer applications. For investors, innovations involving hydrogels can signal growth opportunities in sectors like healthcare, biotechnology, and advanced materials.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it is moving up its shareholder update conference call from Thursday, April 23^rd to Tuesday, April 21^st, 2026, at 4:30 P.M. ET.

Shareholder Update Call Details:
Date: April 21, 2026
Time: 4:30 P.M. ET
Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)
Webcast: Events and Presentations

About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal^®, Hexagels^®, Turfguard^®, Kenkoderm^® and Silly George^®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@KCSA.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the NEXGEL (NXGL) shareholder update call about the Celularity transaction?

The call is scheduled for April 21, 2026 at 4:30 P.M. ET. According to the company, the date was moved up from April 23 to April 21 to discuss the Celularity transaction and related shareholder updates.

How can investors join the NEXGEL (NXGL) April 21, 2026 call on the Celularity transaction?

Investors can dial U.S. toll-free 1-800-267-6316 or international 1-203-518-9783. According to the company, a live webcast is also available via the Events and Presentations section on its investor site.

Will NEXGEL (NXGL) webcast the April 21, 2026 shareholder update on Celularity?

Yes, the company said the event will be available via a live webcast in its Events and Presentations area. According to the company, the webcast provides an online option in addition to the phone dial-in numbers.

Why did NEXGEL (NXGL) move the shareholder update call to April 21, 2026?

The company moved the call earlier to April 21, 2026 to address matters concerning the Celularity transaction. According to the company, the schedule change was made to ensure timely discussion with shareholders.

What will be discussed on the NEXGEL (NXGL) April 21, 2026 shareholder update call?

The call will cover the Celularity transaction and related shareholder information. According to the company, the update is intended to provide investors with details and context about the transaction and next steps.